Introduction
In a recent report by Farzadfar et al. 1 on global trends in serum total cholesterol (TC), it is suggested that HMG-CoA reductase inhibitors (statins) are important for lowering of average TC in high-income countries and that statin use is a likely driver of the polarized trend in average TC seen between low-and high-income countries.
On the other hand, our results show that statins are not a key driver of lowering of average TC in the Icelandic population observed over the last decades. This is further supported by findings from USA, 2 Scandinavia, 3, 4 and Czech Republic. 5 Where the drop in cardiovascular mortality has been examined, by applying the IMPACT model, that examines the contribution of changes in various risk factors and interventions on cardiovascular mortality, the role of reduction in cholesterol levels has been demonstrated and largely shown to be related to other factors than intervention. 6 -9 The tendency to overestimate the impact of effective pharmacological intervention on the population cholesterol level calls for an understanding of which factors have led to the change in population TC. This applies to society at large, but especially to policy makers who need to allocate limited resources in health care and disease prevention in the most efficient way. Physicians have an important role to play to share their knowledge in this context. This is particularly important in the developing countries where cardiovascular diseases are on an increase.
Cholesterol trend
Total cholesterol levels have lowered considerably in most Western populations in the last decades. 1, 2, 10, 11 This is also the case in Iceland as shown in Figure 1A and B. 
Impact of cholesterol changes
The impact of this large decrease in cholesterol on public health is enormous. In Iceland the mortality rate from coronary heart disease declined by 80% between 1981 and 2006. 13 Of this, 32%
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is attributed to the simultaneous drop in population cholesterol levels. 13 This estimate was based on the well-validated IMPACT model. 6 In addition to cholesterol, other risk factors contributed to the drop in CHD mortality and this model addresses the contribution of changes in various cardiovascular risk factors and interventions long known to influence cardiovascular outcomes. Table 1 gives overview of some of the countries where the IMPACT model has been applied. The drop in CHD deaths is 50% in developed countries, but an increase of 50% was seen in males in Beijing, China. 14 The change in cholesterol is smallest in England and Wales: 4.2%.
7 This drop in the cholesterol level was calculated to have prevented 9.6% of CHD deaths. The drop in cholesterol was 6.1% in USA 8 and 6.2% in Italy 15 and 24 and 23% of the lowering of CHD deaths, respectively, was attributed to this. In Iceland 13 and Sweden, 16 the lowering in cholesterol is somewhat more pronounced at 14.5 and 10%, respectively, and the attribution to CHD deaths lowering was 32 and 40%, respectively. The reverse is seen for Beijing where cholesterol levels have increased since 1984. This coincides with an alarming 50% increase in CHD in males in Beijing. This increase in cholesterol was considered consistent with the changes from a traditional diet to a Western diet in Beijing.
14 Statin use in Beijing in the year 1999 was reported only as secondary prevention after myocardial infarction. The use was reported 23% in 1999 in Beijing compared with 25% in England and Wales and 36% in the USA in the year 2000.
Effect of statins on population cholesterol
In the early 1990s, when statins were introduced, the population average TC was unaffected by statin use. The average cholesterol level for females in Iceland without statins in 2008 was 5.11 mmol/L and the population average (which includes also statin users) was 5.10 mmol/L. The average cholesterol level for males without statins was 5.18 mm/L and the population average was 5.10 mmol/L. The fall in TC by statin use is also shown in Figure 2A and B. The trend for individuals not using statins is almost superimposable on the population In the IMPACT papers a regression approach is taken to calculate the numbers of deaths prevented or postponed (NDPP) as a result of a change in risk factor. The formula is NDPP ¼ [1 -exp(coefficient × change in risk factor)] × (expected number of deaths from base year rates), and is applied by sex and within 5-year age groups. The coefficient is a log-hazard rate of death for 1 unit change in the risk factor. The proportion of deaths prevented which is attributed to the risk factor is then the calculated NDPP for the risk factor divided by the total number of deaths prevented or postponed due to changes in disease rates '. b Statin use at the end of the study period.
The lamb supply has been replaced by other meat products, mainly poultry and pork. From the 1990s the consumption of total fat in E% calculated from the food supply statistics has decreased from 40E to 35E%, but the composition of the fat has also changed from more saturated and trans-fatty acids to cis-unsaturated. Similar trend in diet can be seen elsewhere. In Finland, consumption of high-fat milk products and butter decreased by 86 and 67%, respectively, in the period from 1982 to 2007 and consumption of skimmed milk increased by six-fold. 4 The total fat intake in Finland decreased from nearly 40E% in the late 1960s to close to 30E% in 2007. 20 The timing of the largest changes in both diet and cholesterol in Iceland coincides with the introduction of a national nutrition policy by the Icelandic government in the year 1987, where the reduction in saturated fat was greatly emphasized. Subsequently, the Icelandic Nutrition Council elaborated this further in Nutrition recommendations and Nutritional Goals, which had a great influence on nutrition education and awareness in the country. However, it is a limitation to not being able to address the effect of other potentially confounding factors that may have influenced the changes in cholesterol levels, such as physical activity.
Conclusion
The polarized trend in population TC in high-and low-income countries, recently described in the report on global trends lipids, 1 is therefore likely to be driven by difference in awareness about healthy diet and the resulting dietary change rather than pharmacological intervention. Our results demonstrate the importance of collaboration between health scientists, interest groups, and government, and setting and actively implementing nutritional goals at the population level, resulting in a profound impact on the population health.
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